Tapinarof
💊 Brand Formulations & Prices
7 brands sorted by unit price
Tapisis
Pelelisa
Pinarof
Tapina
Tapinor
Tapirof
Vtapa
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesPelelisa 1% cream is indicated for the topical treatment of plaque psoriasis in adult.
Apply a thin layer of Tapinarof cream to affected areas once daily. Wash hands after application, unless Tapisis cream is for treatment of the hands. Tapinarof cream is not for oral, ophthalmic, or intravaginal use.
Pediatric Use
: Safety and efficacy of Tapinarof cream have not been established in pediatric subjects with psoriasis under 18 years of age.
Hypersensitive to any of its components.
Most common adverse reactions (incidence ≥ 1%) in subjects treated with Tapisis cream were folliculitis, nasopharyngitis, contact dermatitis, headache, pruritus, and influenza.
For external use only. Avoid use in eyes, oral or intravaginal use. If there is any unusual allergic reaction with the use of Pelelisa, then treatment should be discontinued and appropriate therapy should be instituted.
This cream contains Tapinarof as the active ingredient. Tapinarof is an Aryl hydrocarbon Receptor (AhR) agonist. The specific mechanisms by which Tapinarof cream exerts its therapeutic action in psoriasis patients are unknown.